1	Impaired	impaired	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	DQ2	dq2	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	DQ8-binding	dq8-binding	_	_	_	_	_	_	_
8	HSV	HSV	_	_	_	_	_	_	_
9	VP16	VP16	_	_	_	_	_	_	_
10	peptide	peptide	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	DQA1*0501/DQB1*0302	dqa1*0501/dqb1*0302	_	_	_	_	_	_	_
14	trans	trans	_	_	_	_	_	_	_
15	class	class	_	_	_	_	_	_	_
16	II	ii	_	_	_	_	_	_	_
17	heterodimer	heterodimer	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	DQalpha	DQalpha	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	DQbeta	DQbeta	_	_	_	_	_	_	_
4	trans	trans	_	_	_	_	_	_	_
5	heterodimeric	heterodimeric	_	_	_	_	_	_	_
6	HLA-DQ	HLA-DQ	_	_	_	_	_	_	_
7	molecules	molecule	_	_	_	_	_	_	_
8	form	form	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	individuals	individual	_	_	_	_	_	_	_
11	heterozygous	heterozygous	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	DQ2	dq2	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	DQ8	dq8	_	_	_	_	_	_	_
17	specificities	specificity	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Unique	unique	_	_	_	_	_	_	_
2	functions	function	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	disease	disease	_	_	_	_	_	_	_
5	associations	association	_	_	_	_	_	_	_
6	have	have	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	postulated	postulate	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	such	such	_	_	_	_	_	_	_
11	trans-dimers	trans-dimer	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	may	may	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	different	different	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	cis-encoded	cis-encoded	_	_	_	_	_	_	_
19	DQ	DQ	_	_	_	_	_	_	_
20	molecules	molecule	_	_	_	_	_	_	_
21	encoded	encode	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	corresponding	correspond	_	_	_	_	_	_	_
25	haplotypes	haplotype	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	analyzed	analyze	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	ability	ability	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	trans-dimer	trans-dimer	_	_	_	_	_	_	_
8	encoded	encode	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	HLA-DQA1*0501/DQB1*0302	hla-dqa1*0501/dqb1*0302	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	bind	bind	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	peptide	peptide	_	_	_	_	_	_	_
15	antigen	antigen	_	_	_	_	_	_	_
16	which	which	_	_	_	_	_	_	_
17	interacts	interact	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	DQ	DQ	_	_	_	_	_	_	_
20	molecules	molecule	_	_	_	_	_	_	_
21	encoded	encode	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	both	both	_	_	_	_	_	_	_
24	parental	parental	_	_	_	_	_	_	_
25	haplotypes	haplotype	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Markedly	markedly	_	_	_	_	_	_	_
2	impaired	impaired	_	_	_	_	_	_	_
3	binding	binding	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	observed	observe	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	consistent	consistent	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	both	both	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	use	use	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	different	different	_	_	_	_	_	_	_
14	anchor	anchor	_	_	_	_	_	_	_
15	residues	residue	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	changes	change	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	levels	level	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	DQ	DQ	_	_	_	_	_	_	_
23	cis-dimer	cis-dimer	_	_	_	_	_	_	_
24	availability	availability	_	_	_	_	_	_	_
25	for	for	_	_	_	_	_	_	_
26	peptide	peptide	_	_	_	_	_	_	_
27	binding	binding	_	_	_	_	_	_	_
28	interactions	interaction	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

